Christoph Kahlert Selected Research

Christoph Kahlert Research Topics

Disease

34	Neoplasms (Cancer) 03/2022 - 03/2008
13	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2008
11	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 06/2011
11	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2011
9	Adenocarcinoma 03/2022 - 02/2014
3	Colonic Neoplasms (Colon Cancer) 01/2016 - 12/2012
2	Stomach Neoplasms (Stomach Cancer) 11/2021 - 11/2015
2	Adenoma (Adenomas) 06/2021 - 07/2019
1	Disease Progression 03/2022
1	Pancreatic Diseases (Pancreatic Disease) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 12/2019
1	Pancreatic Fistula (Pancreatic Fistulas) 12/2019
1	Sinistral Portal Hypertension 12/2019
1	Chronic Pancreatitis 07/2019
1	Cysts 07/2019
1	Fistula 08/2017
1	Carcinogenesis 01/2017
1	Carcinoma (Carcinomatosis) 12/2015
1	Rectal Neoplasms (Rectal Cancer) 12/2012
1	Hypoxia (Hypoxemia) 12/2011
1	Circulating Neoplastic Cells 08/2011
1	Liver Diseases (Liver Disease) 03/2009
1	Dermatomyositis (Dermatopolymyositis) 02/2009
1	Hepatocellular Carcinoma (Hepatoma) 02/2009
1	Lymphatic Metastasis 01/2009
1	Lymphoma (Lymphomas) 03/2008

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2011
5	CytokinesIBA 09/2017 - 02/2011
4	Proteins (Proteins, Gene)FDA Link 06/2021 - 12/2015
3	Messenger RNA (mRNA)IBA 03/2022 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 02/2014
3	MicroRNAs (MicroRNA)IBA 10/2016 - 10/2011
3	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 03/2008
3	Transcription Factors (Transcription Factor)IBA 12/2015 - 12/2011
2	RNA (Ribonucleic Acid)IBA 11/2021 - 12/2019
2	GlypicansIBA 05/2019 - 07/2015
2	Aldehyde DehydrogenaseIBA 12/2012 - 06/2011
2	ParaffinIBA 12/2012 - 06/2011
1	Ion Channels (Ion Channel)IBA 03/2022
1	Transient Receptor Potential ChannelsIBA 03/2022
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2022
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2022
1	Drug CombinationsIBA 01/2022
1	Polysaccharides (Glycans)IBA 08/2021
1	Peptides (Polypeptides)IBA 06/2021
1	GranulinsIBA 06/2021
1	AntigensIBA 12/2020
1	EnzymesIBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	Nucleic AcidsIBA 12/2019
1	Amylases FDA Link 12/2019
1	Long Noncoding RNAIBA 10/2019
1	Culture MediaIBA 07/2019
1	B7-H1 AntigenIBA 07/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	Maraviroc FDA Link 01/2019
1	Epidermal Growth Factor (EGF)IBA 09/2017
1	Interleukin-8 (Interleukin 8)IBA 09/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017
1	A 7 (A-7)IBA 10/2016
1	SurvivinIBA 01/2016
1	ZincIBA 01/2016
1	Protein SIBA 01/2016
1	EndopeptidasesIBA 01/2016
1	CoagulantsIBA 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 01/2016
1	Fluorescein-5-isothiocyanate (FITC)IBA 11/2015
1	Proteoglycans (Proteoglycan)IBA 07/2015
1	Becaplermin (PDGF-BB)FDA Link 12/2014
1	Gemcitabine FDA Link 06/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2013
1	Tumor Biomarkers (Tumor Markers)IBA 04/2013
1	Granzymes (Granzyme)IBA 04/2013
1	Calcibiotic Root Canal SealerIBA 04/2013
1	Zinc Finger E-box Binding Homeobox 2IBA 12/2011
1	DAPIIBA 04/2011
1	LigandsIBA 04/2011
1	Death Domain ReceptorsIBA 04/2011
1	ChemokinesIBA 02/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2011
1	Prednisolone (Predate)FDA LinkGeneric 02/2009
1	Sorafenib (BAY 43-9006)FDA Link 02/2009
1	Cisplatin (Platino)FDA LinkGeneric 01/2009
1	Pharmaceutical PreparationsIBA 09/2008
1	Biological ProductsIBA 09/2008
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2008
1	GelatinasesIBA 03/2008

Therapy/Procedure

7	Therapeutics 01/2022 - 09/2008
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2009
3	Lasers (Laser) 10/2016 - 10/2011
2	Neoadjuvant Therapy 01/2022 - 12/2019
1	Pelvic Exenteration 08/2021
1	Pancreatectomy 12/2019
1	Length of Stay 08/2017
1	Radiotherapy 03/2015
1	Immunotherapy 06/2014
1	Hepatectomy 03/2009
1	Chemoradiotherapy 01/2009